A detailed history of Rafferty Asset Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 3,622 shares of ANIP stock, worth $209,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,622
Holding current value
$209,858
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$53.35 - $61.74 $193,233 - $223,622
3,622 New
3,622 $200,000
Q3 2019

Nov 14, 2019

SELL
$64.7 - $85.39 $686,725 - $906,329
-10,614 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$67.77 - $82.2 $719,310 - $872,470
10,614 New
10,614 $872,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.01B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.